Lisheng Peng
10PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Nov 14, 2023
Does proton pump inhibitors use increase risk of digestive tumors?: A 2-sample Mendelian randomization study.Ruiqi Zhao, Sen Lin, Mengyao Han
|Nov 08, 2022
In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.Zhulin Wu, Jianyuan Kang, Wanjun Tan
|Dec 08, 2021
Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma.Tong Lin, E Zhang, Zhimei Lin
|Nov 08, 2021
ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma.Tong Lin, Yingzhao Zhang, Zhimei Lin
|Jun 04, 2021
CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.Tong Lin, E Zhang, Pei-Pei Mai
|May 17, 2021
Network Pharmacology-Based Investigation of the Therapeutic Mechanisms of Action of Danning Tablets in Nonalcoholic Fatty Liver Disease.Tong Lin, Li Li, Caijun Liang
Pageof 2
